X-linked inhibitor of apoptosis single nucleotide polymorphisms and copy number variation are not risk factors for asthma

Respirology

Volumn 18, Issue 4, 2013, Pages 697-703

  Roscioli, Eugene ^a   Hamon, Rhys ^a   Ruffin, Richard E ^a   Zalewski, Peter ^a   Grant, Janet ^a   Lester, Susan ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

asthma; copy number variation; genetic; single nucleotide polymorphisms; X linked inhibitor of apoptosis protein

Indexed keywords

X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; YOUNG ADULT;

EID: 84876927486     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12065     Document Type: Article

References (36)

1. March ME, Sleiman PM, Hakonarson H,. The genetics of asthma and allergic disorders. Discov. Med. 2011; 11: 35-45.
2. Poon A, Litonjua AA, Laprise C,. Relevance and implication of genetic determinants to asthma pathophysiology. Curr. Opin. Allergy Clin. Immunol. 2011; 11: 407-413.
3. Davies DE, Wicks J, Powell RM, et al. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 2003; 111: 215-225; quiz 26.
4. Holgate ST,. Asthma: a simple concept but in reality a complex disease. Eur. J. Clin. Invest. 2011; 41: 1339-1352.
5. Trautmann A, Kruger K, Akdis M, et al. Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int. Arch. Allergy Immunol. 2005; 138: 142-150. (Pubitemid 41540671)
6. Tumes DJ, Cormie J, Calvert MG, et al. Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lung-derived eosinophils. J. Leukoc. Biol. 2007; 81: 1362-1373. (Pubitemid 46827959)
7. Vignola AM, Chanez P, Chiappara G, et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J. Allergy Clin. Immunol. 1999; 103: 563-573. (Pubitemid 29295559)
8. Vignola AM, Chiappara G, Gagliardo R, et al. Apoptosis and airway inflammation in asthma. Apoptosis 2000; 5: 473-485. (Pubitemid 32162631)
9. Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300-304. (Pubitemid 27317977)
10. Dubrez-Daloz L, Dupoux A, Cartier J,. IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 2008; 7: 1036-1046.
11. Eckelman BP, Salvesen GS, Scott FL,. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006; 7: 988-994. (Pubitemid 44480512)
12. Damgaard RB, Gyrd-Hansen M,. Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity. Discov. Med. 2011; 11: 221-231.
13. Gyrd-Hansen M, Meier P,. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 2010; 10: 561-574.
14. Labbe K, McIntire CR, Doiron K, et al. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 2011; 35: 897-907.
15. Nakamura H, Kawakami A, Yamasaki S, et al. Expression and function of X chromosome-linked inhibitor of apoptosis protein in Sjogren's syndrome. Lab. Invest. 2000; 80: 1421-1427.
16. Zhang HG, Huang N, Liu D, et al. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Arthritis Rheum. 2000; 43: 1094-1105. (Pubitemid 30368190)
17. Aird KM, Ghanayem RB, Peplinski S, et al. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Mol. Cancer Ther. 2010; 9: 1432-1442.
18. Ferretti M, Gattorno M, Chiocchetti A, et al. The 423Q polymorphism of the X-linked inhibitor of apoptosis gene influences monocyte function and is associated with periodic fever. Arthritis Rheum. 2009; 60: 3476-3484.
19. Wu H, Panakanti R, Li F, et al. XIAP gene expression protects beta-cells and human islets from apoptotic cell death. Mol. Pharm. 2010; 7: 1655-1666.
20. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110-114. (Pubitemid 44684766)
21. Weiss KH, Runz H, Noe B, et al. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J. Inherit. Metab. Dis. 2010; DOI 10.1007/s10545-010-9123-5.
22. Serre D, Gurd S, Ge B, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet. 2008; 4: e1000006.
23. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-454. (Pubitemid 44809057)
24. Grant JF, Chittleborough CR, Taylor AW, et al. The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol. Perspect. Innov. 2006; 3: 1-14.
25. Grant JF, Taylor AW, Ruffin RE, et al. Cohort profile: the North West Adelaide Health Study (NWAHS). Int. J. Epidemiol. 2009; 38: 1479-1486.
26. Adams RJ, Wilson DH, Appleton S, et al. Underdiagnosed asthma in South Australia. Thorax 2003; 58: 846-850. (Pubitemid 37239230)
27. The International HapMap project. Nature 2003; 426: 789-796.
28. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
29. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007; 81: 559-575. (Pubitemid 47330214)
30. Tregouet DA, Garelle V,. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007; 23: 1038-1039. (Pubitemid 47050595)
31. Stankiewicz P, Lupski JR,. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 2010; 61: 437-455.
32. Ross MT, Grafham DV, Coffey AJ, et al. The DNA sequence of the human X chromosome. Nature 2005; 434: 325-337. (Pubitemid 40469169)
33. Arriba-Mendez S, Sanz C, Isidoro-Garcia M, et al. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatr. Allergy Immunol. 2006; 17: 323-328. (Pubitemid 43989953)
34. Moller-Larsen S, Nyegaard M, Haagerup A, et al. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 2008; 63: 1064-1069.
35. Ungvari I, Hadadi E, Virag V, et al. Implication of BIRC5 in asthma pathogenesis. Int. Immunol. 2012; 24: 293-301.
36. Hirota T, Obara K, Matsuda A, et al. Association between genetic variation in the gene for death-associated protein-3 (DAP3) and adult asthma. J. Hum. Genet. 2004; 49: 370-375. (Pubitemid 39045036)